Showing results (131-140 of 142) with videos related to
Sort By:
Pageof 15
Blood Cancer Journal|February 29, 2020
Risk-adjusted therapy for pediatric non-T cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02Daiichiro Hasegawa, Toshihiko Imamura, Keiko Yumura-Yagi, et al.Scientific Reports|September 10, 2020
Pluripotent stem cell model of Shwachman-Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitorsTakayuki Hamabata, Katsutsugu Umeda, Kagehiro Kouzuki, et al.International Journal of Hematology|March 8, 2022
JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemiaYoshihiro Takahashi, Hisashi Ishida, Toshihiko Imamura, et al.Transplantation and Cellular Therapy|August 24, 2024
A Retrospective Study of Pediatric Patients With Low- or Intermediate-Risk Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation for the AML-05 Study Conducted by the Japanese Pediatric Leukemia/Lymphoma Study GroupYoshiko Hashii, Koji Kawaguchi, Hiroyuki Kurakami, et al.The Lancet. Haematology|May 11, 2023
Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk groupAtsushi Sato, Yoshihiro Hatta, Chihaya Imai, et al.International Journal of Hematology|December 14, 2022
Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndromeMasahiro Irie, Tetsuya Niihori, Tomohiro Nakano, et al.International Journal of Hematology|February 17, 2026
Outcomes of children with T-cell acute lymphoblastic leukemia treated with the JACLS T-02 protocolHisashi Ishida, Souichi Suenobu, Toshihiko Imamura, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2024
JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALLMotohiro Kato, Yasuhiro Okamoto, Toshihiko Imamura, et al.Pediatric Blood & Cancer|February 25, 2026
Combined Tyrosine Kinase Inhibitors and Chemotherapy Based on Minimal Residual Disease in Children With Ph+ Acute Lymphoblastic Leukemia: A Phase 2 Single-Arm Trial, JCCG ALL-Ph13Atsushi Sato, Yuichi Kodama, Hirohide Kawasaki, et al.The Journal of Pediatrics|July 25, 2009
Identification of severe combined immunodeficiency by T-cell receptor excision circles quantification using neonatal guthrie cardsYoichi Morinishi, Kohsuke Imai, Noriko Nakagawa, et al.Pageof 15